What is Everything Genetic?
Everything Genetic operates at the forefront of personalized medicine, specializing in clinical-grade genetic cancer testing. Their comprehensive services span risk assessment, diagnostic testing, and prognostic evaluations, empowering healthcare providers and individuals with critical information for informed decision-making. The company is committed to disease prevention and proactive healthcare management, offering accessible and affordable testing solutions complemented by extensive pre and post-test clinical support. Their market focus includes healthcare institutions, corporate wellness programs, and direct-to-consumer offerings, positioning them as a key player in the UK's burgeoning genetic testing landscape.
How much funding has Everything Genetic raised?
Everything Genetic has raised a total of $6.3M across 1 funding round:
Debt
$6.3M
Debt (2022): $6.3M with participation from TradePlus24
Key Investors in Everything Genetic
TradePlus24
TradePlus24 is a financial services provider that offers trade finance solutions. Their participation in this debt financing round suggests a focus on supporting operational growth and working capital needs for companies in established markets.
What's next for Everything Genetic?
With substantial enterprise-level backing and a recent strategic investment, Everything Genetic is poised for significant growth and market expansion. The company's focus on clinical-grade diagnostics and comprehensive patient support aligns with the increasing demand for personalized healthcare solutions. Future endeavors will likely involve scaling their distribution network, enhancing their testing technology, and potentially forging new partnerships within the healthcare ecosystem. The company's strategic capital allocation will be crucial in solidifying its position as a leader in genetic cancer testing and driving improved patient outcomes across the UK and potentially beyond.
See full Everything Genetic company page
